Biofrontera USA
Presence
Biofrontera is a company listed under the stock ticker B8F (DE).
Biofrontera has a direct presence in 2 countries.
Executives
View the org chart displaying its 4 main executives
Most searched biographies at Biofrontera USA
- Mark Baldyga, Vice President, Sales and Marketing
- Jon Lyons, Senior Director of Scientific & Medical Affairs
- Erica Gates, Senior Director of Finance
Create your alert
to follow the executive moves at Biofrontera USA.
Pharmaceuticals
Biofrontera has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Biofrontera USA
- PTA-News: Biofrontera AG: BIOFRONTERA REPORTS RESULTS FOR THE FINANCIAL YEAR 2023
- PTA-News: Biofrontera AG: Biofrontera and GME enter into a cooperation to promote the MultiLite® daylight lamp for PDT treatment
- PTA-News: Biofrontera AG: Biofrontera transfers clinical research to the U.S.
- PTA-News: Biofrontera AG: EMA approves an optimized formulation of Ameluz®
- PTA-News: Biofrontera AG: EMA recommends Ameluz® label extension for actinic keratosis treatment with artificial daylight
- PTA-News: Biofrontera AG: Biofrontera Reports Business Performance in the Third Quarter and First Nine Months of 2023
- View more press releases Close
Social media about Biofrontera USA
- Biofrontera USA on Wikipedia, Google News & Yahoo Finance
- Biofrontera USA on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Erica Gates 
Call Biofrontera USA at +1 844...
